HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Cisplatin

TERMINATED · PHASE1 · Cervix Cancer

Low accrual

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.